✓ Pago con tarjeta restablecido — compra segura mediante Privacy Shield

Selank

✅ Ansiolítico sin sedación
✅ Modulación multipathway GABA/BDNF/encefalina
✅ Stress-resilience compound
✅ Péptido biodisponible por vía intranasal
✅ Perfil de abstinencia limpio vs benzodiacepinas

Selank contiene compuesto de péptido sintético.

SKU: N/A Categoría: Etiqueta: ,

✓ Revisado médicamente por Morgan Ellis — Investigador farmacéutico · 8 años de experiencia  · Última revisión: mayo de 2026

Compre más, ahorre más Precio por vial
Seleccione una concentración para ver el precio por paquete.
Pago cifrado
Cripto paga 10% menos
Envío discreto mundial
1.400+ clientes · 50+ países

$50 peptide shipping — dedicated courier applies once per order whenever a Peptides item is in your cart. Product price, this charge, and tax (if any) are shown as separate lines at checkout.

BAC Water
💧 Necesitarás agua BAC para reconstituir este péptido
Agua bacteriostática para inyección — necesaria para mezclar el polvo liofilizado de péptido en una solución inyectable. Un vial de 10 ml reconstituye múltiples viales de péptidos.
Añadir agua BAC (10 ml × 10 Viales, US$50,00) →
¿Ya tienes agua BAC? Omite esto. ¿Necesitas un tamaño de paquete diferente? Ver todos los tamaños →

Respuesta rápida — ¿Qué es el Selank?

Selank is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5 mg and 10 mg lyophilized vials.

Qué obtienes con MedsBase: Pharmaceutical-grade lyophilized peptides · HPLC ≥99% purity (COA on request) · Discreet protective packaging · Worldwide peptide courier · 1,400+ verified opiniones de clientes

📦 Cada pedido está cubierto por nuestra Reshipment Assurance Policy — si tu paquete no llega en 20 días laborables, lo reenviamos.

Especificación Detalle
Número CAS 129954-34-3
Fórmula molecular C33H57N11O9
Peso molecular 751.88 Da
Secuencia Thr-Lys-Pro-Arg-Pro-Gly-Pro-NH2 (TKPRPGP-NH2, 7 aminoácidos; análogo de tuftsina amidado en el extremo C)
Forma Polvo liofilizado (blanco a blanquecino)
Pureza ≥99% (verificado por HPLC, COA bajo solicitud)
Almacenamiento Liofilizado: 2–8 °C (refrigerador) para stock de trabajo; −20 °C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2–8 °C, usar dentro de ~30 días. Proteger de la luz. No congelar-descongelar la solución reconstituida.
Solubilidad Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.

¿Qué es el Selank?

Selank is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed Semax. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank’s well-characterised sequence is TKPRPGP-NH2, peso molecular 751,88 Da, fórmula empírica C33H57N11O9. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our Semax página de producto.

Mecanismo de Acción — Vías GABAérgica, Serotoninérgica y de BDNF

What makes Selank distinctive among anxiolytic compounds is its perfil de neuromodulación multipathway sin unión directa a receptores en el sitio de las benzodiazepinas del GABAA benzodiazepine site — each contributing to the observed anxiolytic and nootropic phenotype in published studies:

  • Modulación GABAérgica sin unión al sitio de las benzodiazepinas — Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank’s pharmacology.
  • Señalización serotoninérgica y encefalinérgica — Published studies has documented increased serotonin metabolism (5-HIAA / 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.
  • Expresión de BDNF y neuroplasticidad — Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank’s nootropic profile — improved memory consolidation and learning performance in rodent maze tasks.

Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset.

Published Evidence

Selank is used in clinical contexts that investigate:

  • Farmacología ansiolítica — pruebas de laberinto elevado más, campo abierto e interacción social en modelos de roedores de ansiedad generalizada; brazos comparativos frente a benzodiazepinas (diazepam) e ISRS (Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)
  • Stress resilience and HPA-axis studies — modelos de estrés crónico leve, estrés por restricción y desamparo aprendido; dinámica del cortisol y la ACTH
  • BDNF and neuroplasticity studies — expresión de BDNF en hipocampo y corteza prefrontal, morfología de espinas dendríticas, electrofisiología de potenciación a largo plazo
  • Cognitive and memory studies — laberinto acuático de Morris, reconocimiento de objetos nuevos, evitación pasiva; efectos nootrópicos independientes de la ansiolisis
  • Inmunomodulación — Selank inherits tuftsin’s immunomodulatory activity, with documented effects on cytokine balance (TNF-α, IL-6, IFN-γ) and macrophage function in published studies
  • Comparative studies vs benzodiazepines — comparación directa con diazepam, alprazolam y fenazepam en eficacia ansiolítica, potencial de dependencia y efecto rebote; el perfil de abstinencia limpio de Selank es uno de los hallazgos más citados en la literatura rusa
  • Sister-peptide studies — evaluación comparativa frente a Semax (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.

For broader context on small-peptide neuromodulation and nootropic studies, see Semax como el comparador nootrópico canónico desarrollado en Rusia, Epitalón for pineal-peptide longevity studies, and BPC-157 for the parallel small-peptide healing-compound. Browse the full catálogo de péptidos para compuestos relacionados.

Concentraciones y potencias disponibles

MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:

Potencia del vial Caso de uso típico Tamaños de paquete
5 mg Short protocols, pilot dosing, intranasal-vehicle formulation studies 10, 20 o 30 viales
10 mg Standard strength, extended protocols, lowest per-mg cost 10, 20 o 30 viales

Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols.

Comparativa: Selank vs Semax

Selank y Semax are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic/neuroprotective.

Criterio Selank Semax
Longitud 7 aminoácidos (heptapéptido) 7 aminoácidos (heptapéptido)
Péptido progenitor Tuftsina (TKPR) Fragmento de ACTH(4-10)
Mecanismo primario Modulación GABA, BDNF, encefalina BDNF, receptores de melanocortina, dopamina
Primary signal Ansiolítico, resiliencia al estrés Nootrópico, neuroprotector, concentración
Typical dose (intranasal) 300–900 mcg/día 200–1.000 mcg/día
Uso clínico en Rusia Ansiolítico aprobado (intranasal) Nootrópico/aprobado para recuperación de ictus (intranasal)
Stacking in studies Frecuentemente combinado con Semax para efecto ansiolítico+nootrópico complementario Frecuentemente combinado con Selank

Because the two peptides act on complementary axes — Selank on GABA/anxiolytic, Semax on melanocortin/dopaminergic/nootropic — they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype.

Almacenamiento y reconstitución

Antes de la reconstitución: almacene los viales liofilizados refrigerados a 2–8 °C en su envase original para stock de trabajo a corto plazo. Para almacenamiento a largo plazo sin abrir, congele a −20 °C. El Selank liofilizado es estable en refrigeración hasta 24 meses y a −20 °C hasta 36 meses. Evite ciclos de congelación-descongelación en el polvo liofilizado. Procedimiento de reconstitución: inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5 mg vial, 1.0 mL of bacteriostatic water yields a 5 mg/mL working concentration; 0.1 mL delivers a 500 mcg dose. Swirl gently — do ajuste shake — and allow 2–5 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100 μL per pump. Después de la reconstitución: almacene refrigerado a 2–8 °C y utilícelo dentro de los 30 días para una estabilidad óptima. No congele la solución reconstituida: los ciclos de congelación-descongelación degradan la integridad del péptido. Deseche cualquier vial que muestre turbidez, precipitado o decoloración.

Preguntas frecuentes

What is Selank used for in studies?

Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is ajuste FDA-approved and is supplied strictly for clinical studies use only.

¿En qué se diferencia Selank de Semax?

Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways — canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation — canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping.

What is the typical Selank dose?

Published Russian protocols typically use 300–900 mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5 mg vial reconstituted with 1.0 mL bacteriostatic water yields 5 mg/mL — 0.1 mL equals 500 mcg, a typical single-dose studies aliquot.

¿Está Selank aprobado por la FDA?

No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez).

¿Cómo debe almacenarse Selank?

Viales liofilizados: refrigerados a 2–8 °C para existencias de trabajo a corto plazo, o −20 °C para almacenamiento a largo plazo de viales sin abrir. Solución reconstituida: refrigerada a 2–8 °C, usar dentro de los 30 días. No congele la solución reconstituida: los ciclos de congelación-descongelación degradan el péptido. Proteja de la luz directa en todo momento.

¿Cómo reconstituyo Selank?

Siga el procedimiento de reconstitución anterior. Añada agua bacteriostática por la pared lateral del vial (no sobre el polvo liofilizado), agite suavemente y permita de 2 a 5 minutos para la disolución completa. No ajuste agite el vial. Una solución correctamente reconstituida es clara e incolora. Para un vial de 5 mg + 1,0 mL de diluyente, la concentración de trabajo es de 5 mg/mL.

¿Qué concentraciones tiene MedsBase en stock?

MedsBase carries Selank in 5 mg and 10 mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.

Can Selank be administered intranasally in studies?

Yes — intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models.

Can Selank and Semax be stacked in studies?

Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA/enkephalin/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin/dopaminergic/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress.

Does Selank cause side reported effects?

Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation — in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review.

¿Cuál es la vida media del Selank?

In preclinical studies, Selank has an estimated plasma half-life of approximately 15–30 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance.

How long does Selank take to show effects in preclinical studies?

Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30–60 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7–14 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models.

¿Puedo pedir Selank para envío internacional?

Sí. MedsBase envía Selank a todo el mundo desde nuestra red dedicada de envío de péptidos. Los pedidos que contienen solo péptidos califican para nuestro servicio de envío independiente de péptidos. Todos los pedidos se envían en embalajes con control de temperatura con seguimiento completo y están cubiertos por nuestro Reshipment Assurance Policy.

Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies

  • Semax — Sister heptapeptide from the same Russian clinical — nootropic and neuroprotective studies
  • Epitalón — AEDG pineal tetrapeptide — longevity and circadian rhythm support
  • BPC-157 — Body Protection Compound — healing and tissue-recovery
  • KPV — Small immunomodulatory tripeptide — inflammation and barrier studies
  • Adamax — Heptapeptide nootropic compound

Lecturas adicionales

📖 Explore small-peptide nootropic studies

Explora toda la catálogo de péptidos, con compuestos relacionados que incluyen Semax for melanocortin-axis nootropic studies, Epitalón for pineal-peptide longevity studies, and Adamax for sister heptapeptide cognitive studies.

Más opciones en Péptidos

Clasificados por volumen de pedidos reciente en MedsBase — lo que otros clientes están eligiendo en esta categoría.

Potencia

5 mg, 10 mg

Cantidad

10 Viales, 20 Viales, 30 Viales

Reseñas

Aún no hay reseñas

Añadir una reseña
Selank Selank
Valoración*
0/5
* La valoración es obligatoria
* La respuesta es obligatoria
Tu reseña
* La reseña es obligatoria
Nombre
* El nombre es obligatorio
Añade fotos o vídeo a tu reseña

Preguntas y respuestas

Haz una pregunta
Selank Selank
Tu pregunta
* La pregunta es obligatoria
Nombre
* El nombre es obligatorio
No hay preguntas aún